(+)-PENTAZOCINE-DEA SCHEDULE IV ITEM结构式
|
常用名 | (+)-PENTAZOCINE-DEA SCHEDULE IV ITEM | 英文名 | (+)-PENTAZOCINE-DEA SCHEDULE IV ITEM |
|---|---|---|---|---|
| CAS号 | 7361-76-4 | 分子量 | 285.424 | |
| 密度 | 1.0±0.1 g/cm3 | 沸点 | 403.5±45.0 °C at 760 mmHg | |
| 分子式 | C19H27NO | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | 180.8±27.4 °C | |
| 符号 |
GHS07 |
信号词 | Warning |
| 英文名 | cis-(+)-pentazocine |
|---|---|
| 英文别名 | 更多 |
| 密度 | 1.0±0.1 g/cm3 |
|---|---|
| 沸点 | 403.5±45.0 °C at 760 mmHg |
| 分子式 | C19H27NO |
| 分子量 | 285.424 |
| 闪点 | 180.8±27.4 °C |
| 精确质量 | 285.209259 |
| LogP | 4.53 |
| 蒸汽压 | 0.0±1.0 mmHg at 25°C |
| 折射率 | 1.554 |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H302-H312-H332 |
| 警示性声明 | P280 |
| 个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
| 危险品运输编码 | NONH for all modes of transport |
|
Allosteric modulation of sigma-1 receptors elicits anti-seizure activities.
Br. J. Pharmacol. 172 , 4052-65, (2015) Application of orthosteric sigma-1 receptor agonists as anti-seizure drugs has been hindered by questionable efficacy and potential adverse effects. Here, we have investigated the anti-seizure effects... |
|
|
Involvement of hypothalamic neuropeptide Y in pentazocine induced suppression of food intake in rats.
Neuropeptides 48(3) , 133-41, (2014) The potent orexigenic peptide neuropeptide Y (NPY) has been considered as a possible endogenous ligand for a subpopulation of sigma receptors (SigR). However, their mutual interaction with reference t... |
|
|
Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain.
J. Med. Chem. 57(24) , 10404-23, (2014) The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (σ1R) antagonists, associated with pharmacological antineuropathic pain activity, are the focus of this article. T... |
| PENTAZOCINE, (+)- |
| 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2S,6S,11S)- |
| (1S,9S,13S)-1,13-Dimethyl-10-(3-methyl-2-buten-1-yl)-10-azatricyclo[7.3.1.02,7]trideca-2,4,6-trien-4-ol |
| (2S,6S,11S)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol |
| A2G9VU2P2J |
| PENTAZOCINE |
| cis-(+)-pentazocine |
| (+)-pentazocine |
| EINECS 206-634-6 |
| α-(+)-Pentazocine |
